Clinical Trial

Effects of Bariatric Surgery on Cardiovascular Risk Profile in Relation to Inflammatory Parameters: Endothelial Phenotyping and Analysis of the Cross-talk Between Adipose Tissue and Endothelium

Study acronym: BARIHEART
Recruiting
View on ClinicalTrials.gov →
Summary
This research project aims to study how obesity affects the heart and metabolism, and how these effects change after significant weight loss following bariatric surgery. In particular, we want to look at how blood vessels and fat tissue function in people with obesity, to detect early signs of vascular problems and understand how fat tissue communicates with blood vessels. Our main idea is that obesity disrupts the normal function of blood vessels, partly due to substances released by fat tissue and changes in gut bacteria. We believe that 6 and 12 months after surgery - with proper weight loss - these problems will gradually improve. We expect to see better blood vessel function and lower levels of inflammation and fat-related substances in the blood, which could significantly reduce the overall risk of heart disease.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-12; most recent amendment 2026-05-04.
Trial Details
NCT Number NCT07131605
Lead Sponsor Maria Cecilia Hospital
Conditions Obesity (Disorder)
Enrollment 85 participants
Start Date 2024-11-11
Primary Completion 2026-11-11 (estimated)
Study Completion 2026-11-11 (estimated)
Updated on ClinicalTrials.gov 2026-05-08